NYLEX 100UI / ml injectible solution medication leaflet

H05BA01 calcitonin (salmon) • Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Calcitonin preparations

Salmon-derived calcitonin is a more potent form of the hormone calcitonin, used for the treatment of osteoporosis, Paget's disease, and hypercalcemia. It works by inhibiting bone resorption and regulating blood calcium levels.

The salmon-derived form is preferred due to its increased efficacy compared to human calcitonin. It is available as injections or nasal spray and is often used as an adjunct therapy.

Salmon calcitonin can reduce bone pain and improve the quality of life for patients with bone-related conditions. It is important that the treatment is administered under medical supervision to minimize risks.

Side effects include nausea, facial flushing, nasal irritation, or allergic reactions. Long-term use is limited due to the risk of cancer associated with prolonged treatment.

General data about NYLEX 100UI / ml

Substance: calcitonin (salmon)

Date of last drug list: 01-07-2020

Commercial code: W08119001

Concentration: 100UI / ml

Pharmaceutical form: injectible solution

Packing volume: 1 ml

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: PROEL E.P. CORONIS SA - GRECIA

Holder: PROEL E.P. CORONIS SA - GRECIA

Number: 1813/2001/01

Shelf life: 2 years

Pharmaceutical forms available for calcitonin (salmon)

Concentrations available for calcitonin (salmon)

100UI, 100UI/dose, 100UI/ml, 200UI/dose, 50UI, 50UI/ml